Flyer

International Journal of Drug Development and Research

  • ISSN: 0975-9344
  • Journal h-index: 51
  • Journal CiteScore: 46.50
  • Journal Impact Factor: 26.99
  • Average acceptance to publication time (5-7 days)
  • Average article processing time (30-45 days) Less than 5 volumes 30 days
    8 - 9 volumes 40 days
    10 and more volumes 45 days
Awards Nomination 20+ Million Readerbase
Indexed In
  • Genamics JournalSeek
  • China National Knowledge Infrastructure (CNKI)
  • CiteFactor
  • Scimago
  • Directory of Research Journal Indexing (DRJI)
  • OCLC- WorldCat
  • Publons
  • MIAR
  • University Grants Commission
  • Euro Pub
  • Google Scholar
  • J-Gate
  • SHERPA ROMEO
  • Secret Search Engine Labs
  • ResearchGate
  • International Committee of Medical Journal Editors (ICMJE)
Share This Page

Abstract

Interpenetrating Polymer Network (IPN): Novel Approach in Drug Delivery

Vineet Bhardwaj, Gargi Harit, Sokindra Kumar

Controlled release drug delivery System (CRDDS) is the major aspect of research in twentieth century into which Interpenetrating polymer network (IPN) based drug delivery system paying the important role in delivering the drug at predetermined rate. IPN is considered as one of the most useful novel biomaterial. Its biocompatible and biodegradable properties made this biomaterial as a novel excipient in the pharmaceutical industry. These systems are also used for tissue engineering such as cartilage scaffolds, bone substitutes etc. The excellent physiochemical attributes such as providing stability to the formulations, improves solubility of hydrophobic drugs, excellent swelling capacity and its biodegradability, impart bioavailability, drug targeting in a specific tissue and very weak antigenecity, made IPN the primary resource in both pharmaceutical and medical applications. IPN offers novel ways to formulator to formulate multiparticulate drug delivery system, tablets or transdermal delivery systems. IPN is highly effective for controlling the drug release of Biopharmaceutics Classification System (BCS) class I drugs.